|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 387.97 PKR | +0.75% |
|
+1.59% | +3.25% |
| 07-14 | Ferozsons Laboratories Limited Appoints Amna Piracha Khan as Chairperson of Board | CI |
| 06-24 | Ferozsons Laboratories Limited Appoints Dr. Parvez Kamal Khan as Director Effective July 7, 2026 | CI |
| Market Cap | 17.53B 63.1M 54.84M 51.2M 47M 88.63M 6.01B 90.17M 604M 236M 3B 237M 232M 9.89B | P/E 2024 |
15.9x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 19.46B 70.08M 60.91M 56.86M 52.2M 98.43M 6.68B 100M 670M 263M 3.33B 263M 257M 10.99B | EV / Sales 2024 |
0.93x | EV / Sales 2025 | 1x |
| Free-Float |
72.55% | Yield 2024 |
1.2% | Yield 2025 | 1.03% |
| 1 day | +0.75% | ||
| 1 week | +1.59% | ||
| Current month | +0.75% | ||
| 1 month | -5.80% | ||
| 3 months | +7.36% | ||
| 6 months | -11.08% | ||
| Current year | +3.25% |
| 1 week | 372.73 | 395 | |
| 1 month | 363 | 416.71 | |
| Current year | 293.01 | 475 | |
| 1 year | 293.01 | 475 | |
| 3 years | 133.11 | 475 | |
| 5 years | 118 | 475 | |
| 10 years | 60.33 | 745.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 1998-12-31 | |
Shahid Toflque
DFI | Director of Finance/CFO | - | 2025-12-18 |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1991-12-31 | |
| Director/Board Member | - | 1998-12-31 | |
| Director/Board Member | - | 1983-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.75% | +1.59% | -3.02% | +118.02% | 60.3M | ||
| -2.39% | -6.36% | +47.10% | +149.66% | 1,024B | ||
| -0.76% | -4.34% | +52.04% | +49.09% | 618B | ||
| -2.33% | -4.60% | +25.55% | +64.44% | 443B | ||
| +0.68% | -1.14% | +38.47% | +33.36% | 349B | ||
| -1.66% | -3.13% | +32.18% | +39.79% | 297B | ||
| -8.96% | -10.77% | +3.57% | +5.50% | 264B | ||
| -1.37% | -7.41% | -2.10% | -43.67% | 209B | ||
| -1.63% | +0.69% | +27.62% | +64.23% | 208B | ||
| +0.72% | +0.48% | +15.88% | +73.64% | 162B | ||
| Average | -1.31% | -2.52% | +23.73% | +55.41% | 357.38B | |
| Weighted average by Cap. | -0.98% | -3.91% | +34.56% | +70.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.85B 57.08M 49.61M 46.32M 42.52M 80.18M 5.44B 81.57M 546M 214M 2.71B 214M 210M 8.95B | 18.86B 67.89M 59.01M 55.09M 50.57M 95.36M 6.47B 97.02M 650M 254M 3.23B 255M 249M 10.64B |
| Net income | 683M 2.46M 2.14M 2M 1.83M 3.45M 234M 3.51M 23.53M 9.22M 117M 9.24M 9.03M 386M | 777M 2.8M 2.43M 2.27M 2.08M 3.93M 266M 4M 26.75M 10.48M 133M 10.5M 10.27M 438M |
| Net Debt | 3.87B 13.94M 12.12M 11.31M 10.38M 19.58M 1.33B 19.92M 133M 52.24M 663M 52.37M 51.21M 2.19B | 1.94B 6.98M 6.07M 5.66M 5.2M 9.8M 665M 9.97M 66.78M 26.15M 332M 26.22M 25.64M 1.09B |
Employees
1,556
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | PKR 387.97 | +0.75% | 11,648 |
| 26-07-31 | PKR 385.10 | +1.34% | 14,269 |
| 26-07-30 | PKR 380.00 | -0.28% | 38,553 |
| 26-07-29 | PKR 381.07 | +1.23% | 13,040 |
| 26-07-28 | PKR 376.43 | -1.43% | 10,168 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- FEROZ Stock
Select your edition
All financial news and data tailored to specific country editions
















